Regulation of acute kidney injury to Candida albicans by b-catenin/TCF pathway

b-catenin/TCF通路调控白色念珠菌急性肾损伤

基本信息

  • 批准号:
    10495218
  • 负责人:
  • 金额:
    $ 19.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-24 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Summary: Candida albicans infection is the third most common infection in hospitalized patients, with a mortality rate ranging between 14.5%–49%. Disseminated candidiasis causes kidney failure resulting in severe morbidity of the immunocompromised host such as those with acquired immune deficiency syndrome or cancer, organ or bone marrow transplant patients, or patients taking immunosuppressant drugs an extended period of time. Prevention and treatment of disseminated candidiasis are an important clinical problem, and currently, there are no approved vaccines against any fungal pathogens. However, the cellular and molecular mechanisms underlying renal failure caused by pathogenic Candida albicans infection remain largely unknown. The immune system plays an important role in protecting against disseminated candidiasis. Immune activating pathways in renal antigen-presenting cells (APCs) play a critical role in inducing robust immune responses in the kidney against C. albicans. In contrast, the anti-inflammatory pathways in APCs suppress immune responses in the kidney against C. albicans and increasing susceptibility to kidney damage and failure. Thus, identifying the signaling pathways that program APCs towards an immunogenic state versus a regulatory state will help identify new targets for therapeutic manipulation of immune cells that augments kidney immunity against Candida albicans and protects against infection-associated-kidney damage and failure. We have identified a new and previously unsuspected role for β-catenin and TCF4 as a key molecular anti-inflammatory pathway in APCs that is critical for suppressing immune responses against disseminated candidiasis, causing increased susceptibility to kidney damage and failure. This application aims to delineate the molecular mechanisms by which β-catenin and TCF4 metabolically program renal APCs against disseminated candidiasis and its impact on kidney function.
摘要:白色念珠菌感染是住院患者中第三常见的感染, 死亡率在 14.5%–49% 之间。播散性念珠菌病会导致肾衰竭。 免疫功能低下的宿主(例如患有获得性免疫缺陷综合征的宿主)的严重发病率 或癌症、器官或骨髓移植患者,或长期服用免疫抑制剂的患者 传播性念珠菌病的预防和治疗是一个重要的临床问题,并且 目前,还没有针对任何真菌病原体的批准疫苗,但是,细胞和分子疫苗。 致病性白色念珠菌感染引起肾衰竭的机制仍然很大程度上未知。 免疫系统在预防播散性念珠菌病方面发挥着重要作用。 抗原呈递细胞 (APC) 中的肾脏通路在诱导强有力的免疫反应中发挥着关键作用 相反,APC 中的抗炎途径会抑制免疫。 肾脏对白色念珠菌的反应,增加对肾脏损伤和衰竭的易感性。 确定将 APC 编程为免疫原性状态与调节状态的信号通路 将有助于确定免疫细胞治疗操作的新靶点,从而增强肾脏免疫力 对抗白色念珠菌并防止感染相关的肾脏损伤和衰竭。 确定了 β-catenin 和 TCF4 作为关键抗炎分子的新的且先前未曾怀疑的作用 APC 中的通路对于抑制针对播散性念珠菌病的免疫反应至关重要,导致 增加对肾脏损伤和衰竭的易感性。该应用旨在描述分子。 β-连环蛋白和 TCF4 代谢编程肾 APC 对抗播散性的机制 念珠菌病及其对肾功能的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Santhakumar Manicassamy其他文献

Santhakumar Manicassamy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Santhakumar Manicassamy', 18)}}的其他基金

Regulation of acute kidney injury to Candida albicans by b-catenin/TCF pathway
b-catenin/TCF通路调控白色念珠菌急性肾损伤
  • 批准号:
    10373167
  • 财政年份:
    2021
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of colitis associated with acute kidney injury by the Wnt pathway
Wnt 通路调节与急性肾损伤相关的结肠炎
  • 批准号:
    10084294
  • 财政年份:
    2020
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of colitis associated with acute kidney injury by the Wnt pathway
Wnt 通路调节与急性肾损伤相关的结肠炎
  • 批准号:
    10320015
  • 财政年份:
    2020
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of colitis associated with acute kidney injury by the Wnt pathway
Wnt 通路调节与急性肾损伤相关的结肠炎
  • 批准号:
    10542352
  • 财政年份:
    2020
  • 资助金额:
    $ 19.25万
  • 项目类别:
Programming dendritic cells to induce tolerogenic response and suppress brain inf
对树突状细胞进行编程以诱导耐受反应并抑制大脑信息
  • 批准号:
    8716336
  • 财政年份:
    2013
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of Oral Tolerance and Intestinal Inflammation by Beta-catenin/TCF Path
Beta-catenin/TCF 路径对口服耐受性和肠道炎症的调节
  • 批准号:
    8688238
  • 财政年份:
    2012
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of Oral Tolerance and Intestinal Inflammation by Beta-catenin/TCF Path
Beta-catenin/TCF 路径对口服耐受性和肠道炎症的调节
  • 批准号:
    8547805
  • 财政年份:
    2012
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of Oral Tolerance and Intestinal Inflammation by Beta-catenin/TCF Path
Beta-catenin/TCF 路径对口服耐受性和肠道炎症的调节
  • 批准号:
    9079468
  • 财政年份:
    2012
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of Oral Tolerance and Intestinal Inflammation by Beta-catenin/TCF Path
Beta-catenin/TCF 路径对口服耐受性和肠道炎症的调节
  • 批准号:
    8421463
  • 财政年份:
    2012
  • 资助金额:
    $ 19.25万
  • 项目类别:

相似海外基金

The protective role of kidney-derived Tamm Horsfall protein (Uromodulin) in sepsis
肾源性 Tamm Horsfall 蛋白(尿调节蛋白)在脓毒症中的保护作用
  • 批准号:
    10886979
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
Real-time Prediction of Adverse Outcomes After Surgery
实时预测手术后不良后果
  • 批准号:
    10724048
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
ShEEP Request for MESO SECTOR S 600MM Ultra-Sensitive Plate Imager
ShEEP 请求 MESO SECTOR S 600MM 超灵敏板成像仪
  • 批准号:
    10741205
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
TIGIT in acute kidney injury and repair
TIGIT在急性肾损伤和修复中的作用
  • 批准号:
    10584173
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
Harnessing hypoxia responses to treat postischemic kidney injury and inflammation
利用缺氧反应治疗缺血后肾损伤和炎症
  • 批准号:
    10676938
  • 财政年份:
    2022
  • 资助金额:
    $ 19.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了